Summary by Futu AI
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company, with an aggregate market value of $97,040.46, on 07/23/2024. These shares were originally acquired on 09/01/2016 as founder's shares and were part of Blake's compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $688,144.26.